Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk: a meta-analysis from 41 studies with 16,480 cases and 22,388 controls

Author： Qi Xiaowei

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.123, Iss.2, 2010-09, pp. : 499-506

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk in Chinese population: a meta-analysis of 22 case–control studies

By Liang Hongjie Yan Yulan Li Taijie Li Ruolin Li Meng Li Shan Qin Xue

Tumor Biology, Vol. 35, Iss. 2, 2014-02 ,pp. : 1695-1701

Springer Publishing Company

Access to resources Recommend Favorite

Methylenetetrahydrofolate reductase gene polymorphisms association with the risk of diffuse large B cell lymphoma: a meta-analysis

By Sun Yun-Yu An Li Xie Yu-Lan Xu Jing-Yan Wang Jing

Tumor Biology, Vol. 34, Iss. 6, 2013-12 ,pp. : 3587-3591

Springer Publishing Company

Access to resources Recommend Favorite

Genetic polymorphisms of methylenetetrahydrofolate reductase (MTHFR) gene Ala222Val and susceptibility to ovary cancer: a systematic review and meta-analysis

By Pan Xinwei Lu Yan Long Ying Yao Desheng

Tumor Biology, Vol. 35, Iss. 3, 2014-03 ,pp. : 2133-2139

Springer Publishing Company

Access to resources Recommend Favorite

TGFB1 T29C polymorphism and breast cancer risk: a meta-analysis based on 10,417 cases and 11,455 controls

By Gu Dongying

Breast Cancer Research and Treatment, Vol. 123, Iss. 3, 2010-10 ,pp. : 857-861

Springer Publishing Company

Access to resources Recommend Favorite

Transforming growth factor-1 polymorphisms and breast cancer risk: a meta-analysis based on 27 case–control studies

By Qi Xiaowei

Breast Cancer Research and Treatment, Vol. 122, Iss. 1, 2010-07 ,pp. : 273-279

Springer Publishing Company

Access to resources Recommend Favorite